Landaas & Company’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-33
Closed 348
2017
Q4
$0 Hold
33
﹤0.01% 376
2017
Q3
$0 Buy
+33
New ﹤0.01% 353